CBAY stock news

CymaBay (NASDAQ: CBAY) Stock Soars as Gilead Sciences Unveils $4.3 Billion Takeover Bid

CymaBay Therapeutics (NASDAQ: CBAY) stock skyrocketed after Gilead Sciences (GILD) announced to acquire the liver disease drugmaker for $4.3 billion on Monday. U.S. drugmaker Gilead Sciences (NASDAQ: GILD) has announced to buy CymaBay Therapeutics (CBAY) for $4.3 billion. This acquisition, […]

CymaBay (NASDAQ: CBAY) Stock Soars as Gilead Sciences Unveils $4.3 Billion Takeover Bid Read More ยป